参考文献:
[1 ]Ridker PM,Cushman M,Stampfer MJ ,et al . Inflammation ,aspirin ,and therisk of cardiovascular disease in apparently healthy men [ J ] . N Engl JMed. 1997 ,336 (14) :973.
[2 ]Ridker PM,Glynn RJ ,Hennekens CH. C2reactive protein adds to the pre2dictive value of total and HDL cholesterol in determining risk of first my2ocardial infarction [J ] . Circulation ,1998 ,97 :20071
[3 ]Ridker PM,Hennekens CH ,Buring JE ,et al . C2Reactive protein and othermarkers of inflammation in the prediction of cardiovascular disease inwomen [J ] . N Engl J Med ,2000 ,342 :836.
[4 ]Pankow JS ,Folsom AR ,Cushman M,et al . Familial and genetic determi2nants of systemic markers of inflammation : the NHLBI family heart study
[J ] . Atherosclerosis ,2001 ,154 :681.
[5 ]本杰明. 卢因1 基因Ⅷ [M]1 北京,科学出版社,2007 :591
[6 ]Cao H ,Hegele RA. Human C2reactive protein (CRP) 1059G/ C polymor2phism [J ] . J Hum Genet ,2000 ,45 (2) :100.
[7 ]Crawford DC ,Yi Q ,Smith JD ,et al . Allelic spectrum of the natural varia2tion in CRP[J ] . Hum Genet ,2006 ,119 (5) :496.
[8 ]Szalai AJ ,McCrory MA ,Cooper GS , et al . Association between baselinelevels of C2reactive protein (CRP) and a dinucleotide repeat polymorphismin the intron of the CRP gene[J ] . Genes Immun ,2002 ,3 (1) :14.
[9 ]Brull DJ ,Serrano N ,Zito F ,et al . Human CRP gene polymorphism influ2ences CRP levels :implications for the prediction and pathogenesis of coro2nary heart disease[ J ] .Arterioscler Thromb Vasc Biol , 2003 , 23 ( 11) :2063.
[10 ]Suk HJ ,Ridker PM,Cook NR ,et al . Relation of polymorphism within theC2reactive protein gene and plasma CRP levels [ J ] . Atherosclerosis.2005 ,178 (1) :139.
[11 ]Kathiresan S ,Larson MG,Vasan RS ,et al . Contribution of clinical corre2lates and 13C2reactive protein gene polymorphisms to interindividualvariability in serum C2reactive protein level [J ] . Circulation ,2006 ,113(11) :1415.
[12 ]Morita A ,Nakayama T ,Doba N , et al . Polymorphism of the C2reactiveprotein (CRP) gene is related to serum CRP level and arterial pulse wavevelocity in healthy elderly Japanese [J ] . Hypertens Res ,2006 ,29 (5) :323.
[13 ]D’Aiuto F ,Casas JP ,Shah T ,et al . C2reactive protein ( + 1444C > T)polymorphism influences CRP response following a moderate inflammatorystimulus[J ] .Atherosclerosis ,2005 ,179 (2) :413.
[14 ]Obisesan TO ,Leeuwenburgh C ,Ferrell RE ,et al . C2reactive protein geno2type affects exercise training2induced changes in insulin sensitivity[J ] .Metabolism,2006 ,55 (4) :453.
[15 ]Zee RY,Hegener HH ,Fernandez2Cruz A ,et al . C2reactive protein genepolymorphisms and the incidence of post2angioplasty restenosis [ J ] .Atherosclerosis ,2004 ,176(2) :393.
[16 ]Lange LA ,Carlson CS ,Hindorff LA ,et al . Association of polymorphismsin the CRP gene with circulating C2reactive protein levels and cardiovas2cular events [J ] . JAMA ,2006 ,296 (22) :2703.
[ 17 ]Kovacs A ,Green F ,Hansson LO ,et al . A novel common single nucleotidepolymorphism in the promoter region of the C2reactive protein gene asso2ciated with the plasma concentration of C2reactive protein [ J ] .Atherosclerosis ,2005 ,178(1) :193.
[18 ]Miller DT ,Zee RY,Suk Danik J ,et al . Association of common CRP genevariants with CRP levels and cardiovascular events [J ] . Ann Hum Genet ,2005 ,69 :623.
[19 ]Szalai AJ ,Wu J ,Lange EM,et al . Single2nucleotide polymorphisms in theC2reactive protein (CRP) gene promoter that affect transcription factorbinding, alter transcriptional activity , and associate with differences inbaseline serum CRP level [J ] . J MolMed ,2005 ,83(6) :440.
[20 ]Crawford DC ,Sanders CL ,Qin X,et al . Genetic variation is associatedwith C2reactive protein levels in the third National Health and NutritionExamination Survey [J ] . Circulation ,2006 ,114 (23) :2458.
[21 ] Zee RY, Ridker PM. Polymorphism in the human C2reactive protein(CRP) gene ,plasma concentrations of CRP ,and the risk of future arterialthrombosis [J ] .Atherosclerosis ,2002 ,162(1) :217.
[22 ] Kardys I , de Maat MP ,Uitterlinden AG,et al . C2reactive protein genehaplotypes and risk of coronary heart disease : the Rotterdam Study [J ] .Eur Heart J ,2006 ,27(11) :1331.
[23 ]徐 耕,金国栋,傅国胜,等1 冠心病患者C 反应蛋白水平及其1059G- C 基因多态性的研究[J ] . 中华心血管病杂志,2003 ,31(4) :2741
[24 ]尚小明,赵宝春,戴秀华,等1 不同类型炎症在冠心病发病中的意义2C2反应蛋白水平与基因型分析[J ]1 国外医学·内科学分册,2005 ,32(6) :2691
[25 ]Rizzello V ,Liuzzo G,et al . 1059G/ C polymorphism within the exon 2 ofthe C2reactive protein gene : relationship to C2reactive protein levels andprognosis in unstable angina[J ] . Coron Artery Dis ,2007 ,18 (7) :533.
[26 ]Pai JK,Mukamal KJ ,et al . C2Reactive Protein (CRP) Gene Polymor2phisms ,CRP Levels ,and Risk of Incident Coronary Heart Disease in TwoNested Case2Control Studies[J ] . PLoS ONE ,2008 ,2 ;3 (1) :e1395.
[27 ]Morita A ,Nakayama T ,Soma M. Association study between C2reactiveprotein genes and ischemic stroke in Japanese subjects [J ] . AmJ Hyper2tens ,2006 ,19(6) :593.
[ 28 ]Chen J ,Zhao J ,Gu D ,et al . - 717A > Gpolymorphismof human C2reac2tive protein gene associated with coronary heart disease in ethnic HanChinese : the Beijing atherosclerosis study [J ] . J Mol Med ,2005 ,83(1) :72.
[29 ] Kovacs A , Green F ,et al . A novel common single nucleotide polymor2phism in the promoter region of the C2reactive protein gene associatedwith the plasma concentration of C2reactive protein [J ] . Atherosclerosis ,2005 ,178 (1) :193.
[30 ]Eklund C ,Islam MS ,et al . C2reactive protein genetics is associated withcarotid artery compliance in men in The Cardiovascular Risk in YoungFinns Study[J ] . Atherosclerosis ,2008 ,196(2) :841.
作者署名的意义及原则
论文的作者应在发表的作品上署名。署名者可以是个人作者、合作作者或团体作者,是拥有著作权的声明。
《中华人民共和国著作权法》规定:著作权属于作者。著作权包括发表权、署名权、修改权、保护作品完整权等署名权即表明作者在作品上署名的权利;署名表明作者的劳动成果及作者本人都得到了社会的承认和尊重,即作者向社会声明,作者对该作品拥有了著作权。署名是文责自负的承诺,文责自负,是指论文一经发表,署名者对作品负有责任,包括政治上、科学上和法律上的责任。如果文章中存在剽窃、抄袭的内容,或者有政治性、技术性错误,署名者即应负完全的责任,署名即表明作者愿意承担责任。署名便于读者与作者联系,也表示作者有同读者联系的意愿。
论文的署名者应具备以下条件: ①本人应是直接参加课题研究的全部或主要部分的工作,并做出主要贡献者; ②本人应为作品创作者,并为作品的直接责任者; ③本人对作品具有答辩能力,并为作品的直接责任者。
多位作者共同完成的作品联合署名时,署名顺序按对该文的贡献大小排列。第一作者是主要贡献者和直接创作者,同时又是作品的直接责任者,享有更多的权利,承担着更多的义务。除有特别声明外,第一作者就是第一权利、第一责任和第一义务者。
有的人虽是课题研究组成员,参加了部分研究或实验工作,但由于其工作性质是辅助性的,不应列为作者;也有人对研究工作确有贡献,并对成果有答辩能力,但未直接参加作品的创作工作,也不宜作为论文的作者。作者应是上述三原则的同时具备者。不够署名条件但确对研究成果有所贡献者可在文末致谢。